Recombinant multi-species PKMYT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PKMYT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the serine/threonine protein kinase family. The encoded protein is a membrane-associated kinase that negatively regulates the G2/M transition of the cell cycle by phosphorylating and inactivating cyclin-dependent kinase 1. The activity of the encoded protein is regulated by polo-like kinase 1. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]
The Alternative Names of target: 6230424P17,MYT1,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,Myt1,Myt1 kinase,PKMYT1,PPP1R126,Pkmyt1,RGD1305434

Target products collectionGo to PKMYT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0113-Ag-1/ GM-Tg-hg-IP0113-Ag-2 Human PKMYT1 protein Human
GM-Tg-rg-IP0113-Ag-1/ GM-Tg-rg-IP0113-Ag-2 Rat PKMYT1 protein Rat
GM-Tg-mg-IP0113-Ag-1/ GM-Tg-mg-IP0113-Ag-2 Mouse PKMYT1 protein Mouse
GM-Tg-cynog-IP0113-Ag-1/ GM-Tg-cynog-IP0113-Ag-2 Cynomolgus/Rhesus macaque PKMYT1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0113-Ag-1/ GM-Tg-felg-IP0113-Ag-2 Feline PKMYT1 protein Feline
GM-Tg-cang-IP0113-Ag-1/ GM-Tg-cang-IP0113-Ag-2 Canine PKMYT1 protein Canine
GM-Tg-bovg-IP0113-Ag-1/ GM-Tg-bovg-IP0113-Ag-2 Bovine PKMYT1 protein Bovine
GM-Tg-equg-IP0113-Ag-1/ GM-Tg-equg-IP0113-Ag-2 Equine PKMYT1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0113-Ag-1/ GM-Tg-hg-IP0113-Ag-2; GM-Tg-rg-IP0113-Ag-1/ GM-Tg-rg-IP0113-Ag-2;
GM-Tg-mg-IP0113-Ag-1/ GM-Tg-mg-IP0113-Ag-2; GM-Tg-cynog-IP0113-Ag-1/ GM-Tg-cynog-IP0113-Ag-2;
GM-Tg-felg-IP0113-Ag-1/ GM-Tg-felg-IP0113-Ag-2; GM-Tg-cang-IP0113-Ag-1/ GM-Tg-cang-IP0113-Ag-2;
GM-Tg-bovg-IP0113-Ag-1/ GM-Tg-bovg-IP0113-Ag-2; GM-Tg-equg-IP0113-Ag-1/ GM-Tg-equg-IP0113-Ag-2
Products Name PKMYT1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PKMYT1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PKMYT1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.